U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147569) titled 'TAMBE Japan Post-Marketing Surveillance' on Aug. 19.
Brief Summary: To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE(R) EXCLUDER(R) Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Study Start Date: Dec. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Thoracoabdominal Aortic Aneurysm
Pararenal Aortic Aneurysm
Intervention:
DEVICE: GORE(R) EXCLUDER(R) Thoracoabdominal Branch Endoprosthesis
The target patients are those who were attempted to implant the AC during the enrollment period of this surveillance. Patients will also be targeted even if all ...